Jay Matushak Sells 4,448 Shares of NeueHealth, Inc. (NYSE:NEUE) Stock

NeueHealth, Inc. (NYSE:NEUE) CFO Jay Matushak sold 4,448 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total value of $29,979.52. Following the completion of the sale, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. This represents a 9.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Jay Matushak also recently made the following trade(s):

• On Tuesday, March 11th, Jay Matushak sold 814 shares of NeueHealth stock. The stock was sold at an average price of $6.85, for a total value of $5,575.90.
• On Friday, March 7th, Jay Matushak sold 1,860 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total transaction of $13,373.40.
• On Monday, January 6th, Jay Matushak sold 4,970 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total transaction of $36,430.10.

NeueHealth Stock Performance

Shares of NeueHealth stock traded down $0.38 during trading hours on Monday, hitting $4.71. The company’s stock had a trading volume of 81,052 shares, compared to its average volume of 18,693. The stock has a market cap of $38.98 million, a price-to-earnings ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The firm has a fifty day moving average of $7.21 and a 200-day moving average of $6.01.

Institutional Trading of NeueHealth

Institutional investors and hedge funds have recently bought and sold shares of the stock. Partners Group Holding AG purchased a new position in NeueHealth during the third quarter worth about $463,000. Northern Trust Corp lifted its holdings in shares of NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in shares of NeueHealth during the 4th quarter worth approximately $76,000. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reduced their price target on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.